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Objectives: Bipolar disorder (BD) is frequently misdiagnosed as major
depressive disorder (MDD), which may lead to inappropriate treatment
and poor outcomes. This study aimed to compare demographic and
clinical features between patients with MDD and those with BD, but
being misdiagnosed as MDD, in China.
Methods: A total of 1487 patients diagnosed with MDD were
consecutively evaluated in 13 psychiatric hospitals or psychiatric units of
general hospitals nationwide in China. The patients’ sociodemographic
and clinical characteristics were recorded using a standardized protocol
and data collection procedure. The Mini-International Neuropsychiatric
Interview (MINI) was used to establish DSM-IV diagnoses, and identify
patients with MDD and those with BD, but being misdiagnosed with
MDD.
Results: The proportions of BD (all types), bipolar I disorder (BD-I),
and bipolar II disorder (BD-II) misdiagnosed as MDD in clinical practice
were 20.8%, 7.9%, and 12.8%, respectively. Multiple logistic regression
analyses revealed that compared to MDD patients, BD-I was
characterized by more atypical depressive features (increased appetite,
increased sleep, and weight gain) [odds ratio (OR) = 2.0, 95% confidence
interval (CI): 1.2–3.2], more psychotic symptoms (OR = 2.1, 95% CI: 1.3
–3.5), more lifetime depressive episodes (OR = 1.1, 95% CI: 1.1–1.2), and
earlier age of onset (OR = 0.97, 95% CI: 0.9–0.99); BD-II was
characterized by more psychotic symptoms (OR = 2.1, 95% CI: 1.4–3.1)
and earlier age of onset (OR = 0.96, 95% CI: 0.9–0.97). In addition,
compared to BD-II patients, BD-I patients were characterized by more
frequent depressive episodes per year (OR = 3.1, 95% CI: 1.5–6.6).
Conclusions: Depressive episodes in the context of BD-I and BD-II,
among those who were misclassified as MDD, present some different
clinical features compared to MDD. This finding should be taken into
account in guiding diagnostic practices in China.
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In clinical practice, diagnostic criteria for bipolar I
disorder (BD-I) and bipolar II disorder (BD-II)
depend on the presence or absence of manic or
hypomanic episodes. A depressive episode is usu-
ally the first mood syndrome at the onset of bipo-
lar disorder (BD), and depressive episodes are
Affiliations for all authors are listed before the references.
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more frequent than manic or hypomanic episodes
(1). Hypomania is often viewed as a normal experi-
ence by patients and therefore can be underreport-
ed (2). Also, clinicians do not always ask depressed
patients about hypomania (3), and some depressed
patients have not yet experienced a manic or hypo-
manic episode (4). As a result, patients with BD,
particularly BD-II, are frequently misdiagnosed
with major depressive disorder (MDD) and may
receive inadequate or inappropriate treatment (2, 5).
Thus, early identification of BD is of crucial
importance.
Given the important implications for treatment
and prognosis of BD, in the past few decades a
number of studies have consistently identified soci-
odemographic, clinical-phenomenological, and
biological differences between bipolar depression
and MDD. Compared to MDD, commonly
reported features of bipolar depression included
younger age of onset, shorter duration of episodes,
more prior episodes, social withdrawal, hypersom-
nia, hyperphagia, lability of mood, psychotic fea-
tures, psychomotor retardation, and family history
of BD (6). These findings were almost entirely
based on studies of Western populations. Evidence
suggests that features of mood disorders are not
independent of the complex interplay of the bio-
psychosocial environment (7). It has been pointed
out that Western psychiatric textbooks, diagnostic
systems, and research findings do not cover the full
range of mood symptoms experienced by Chinese
patients (8, 9). Therefore, it is necessary to examine
the demographic and clinical-phenomenological
differences between bipolar depression and MDD
in China.
This study examined whether BD patients misdi-
agnosed with MDD differ from those with MDD
in terms of demographic and clinical features in
Chinese clinical settings.
Methods
Study participants and settings
This study was part of the Diagnostic Assessment
Service for People with Bipolar Disorders in China
(DASP), which is an ongoing nationwide study
initiated by the Chinese Society of Psychiatry
(CSP), and aims to develop and test the usefulness
of screening tools for BD in patients treated for
MDD. Participants in the project were recruited
in 13 major psychiatric hospitals/units [Beijing
Anding Hospital (n = 177), Peking University
Institute of Mental Health (n = 41), Beijing Hui-
longguan Hospital (n = 60), Shanghai Mental
Health Center (n = 216), Shanghai Tongji
Hospital (n = 39), Shenzhen Mental Health Centre
(n = 140), the First Hospital of Harbin Medical
University (n = 123), Hangzhou Seventh People’s
Hospital (n = 87), West China Hospital (n = 73),
the Affiliated Brain Hospital of Nanjing Medical
University (n = 166), Mental Health Institute of
the Second Xiangya Hospital (n = 102), the Sec-
ond Affiliated Hospital of Zhejiang University
(n = 153), and the Third Affiliated Hospital of Sun
Yat-Sen University (n = 110)] located in north,
south, east, west, and central parts of China, and
representing a range of clinical settings. The study
period lasted from September 1, 2010 to February
28, 2011. Patients were enrolled if they were
between 16 and 65 years old, were inpatients or
outpatients, had a diagnosis of DSM-IV or ICD-10
MDD based on a review of medical records,
understood the aims of the study, and provided
informed consent. Exclusion criteria included: (i) a
past diagnosis of BD; (ii) a history of or ongoing
significant medical or neurological condition(s);
(iii) depressive disorders secondary to a general
medical or neurological condition; and (iv) having
received electroconvulsive therapy (ECT) in the
past month. The study protocol was approved by
the Clinical Research Ethics Committees of the
respective study centers.
Instrument and assessment procedure
Patients with MDD who were receiving treatment
in the participating hospitals/units were consecu-
tively referred by their treating psychiatrists to the
research team during the study period to be
screened for eligibility. Patients fulfilling the study
entry criteria were invited to participate in the
study.
Patients’ basic sociodemographic and clinical
data were collected in a clinical interview with a
questionnaire designed for the study and were sup-
plemented by a review of their medical records
(Table 1). The diagnostic assessment of BD was
conducted with the Chinese version of the Mini-
International Neuropsychiatric Interview (MINI),
Version 5.0, to establish DSM-IV BD-I/BD-II
diagnoses (10, 11). High recurrence was defined as
more than four major depressive episodes per year.
The number of major depressive episodes was
counted based on a review of medical records; to be
considered as separate episodes, there had to be an
interval of at least two consecutive months between
episodes during which criteria were not met for an
MDD. Age at onset was defined as onset of the first
major depressive or manic episode (12).
Prior to the study, all 13 raters were trained in
the use of MINI in diagnosing BD in 20 patients
200
Xiang et al.
treated for MDD. In this reliability exercise, their
judgments of BD were compared to those of the
best estimate clinical diagnoses (15 of the 20
patients were BD patients); the kappa values were
>0.85. Whenever possible, the same raters evalu-
ated the same group of patients throughout the
study. After providing written consent following a
full explanation about the study, patients met a
rater for a confirmatory diagnostic interview based
on DSM-IV criteria using the MINI supplemented
by a review of medical records and, whenever pos-
sible, an interview of relatives.
Statistical analysis
Data were analyzed using SPSS 13.0 (SPSS Inc.,
Chicago, IL, USA). Descriptive statistics were used
to characterize the patients’ sociodemographic and
clinical features. Comparisons of the sociodemo-
graphic and clinical characteristics of patients with
BD-I, BD-II, and MDD were performed by one-
way analysis of variance (ANOVA) or the
chi-square test, as appropriate. If these tests were
significant, post-hoc tests were carried out. Step-
wise multiple logistic regression analyses were used
to compare demographic and clinical variables
between MDD and BD-I, between MDD and
BD-II, and between BD-I and BD-II. In the regres-
sion analyses, the diagnosis based on the MINI
(MDD/BD-I, MDD/BD-II, and BD-I/BD-II) was
entered as the dependent variable separately and
all variables that showed a significant difference
between the three groups in the aforementioned
univariate analyses (age, gender, marital status,
frequent depressive episodes, atypical depressive
features, depressive episodes with suicidal ideation
and/or attempts, psychotic symptoms, lifetime
depressive episodes, seasonal depressive episodes,
family history of psychiatric disorders, and age of
onset) were entered as independent variables after
study site was controlled for. The level of signifi-
cance was set at 0.05 (two-tailed).
Results
In total, 1757 patients were screened and invited to
participate in this study; 270 (15.4%) refused to
participate or failed to complete the interview.
There was no significant difference between the
study patients and those who refused to participate
or failed to complete the assessment in terms of
age and gender. A total of 1487 patients were
included in the analysis.
Of the 1487 patients, 309 (20.8%) satisfied
DSM-IV criteria for BD; 118 (7.9%) for BD-I and
191 (12.8%) for BD-II. Table 1 displays the
sociodemographic and clinical characteristics of
the whole sample as well as separately for patients
by diagnosis. Compared to MDD patients, BD-I
patients were more likely to be male, had more fre-
quent depressive episodes (more than four epi-
sodes/year), more atypical depressive features
(increased appetite, increased sleep, and weight
gain), suicide ideation and attempts, psychotic
symptoms, more seasonal depressive episodes, a
stronger family history of psychiatric disorders,
more lifetime depressive episodes, younger age,
and earlier age at onset. Compared to MDD
patients, BD-II patients were more likely to be
male and married, had more atypical depressive
features (increased appetite, increased sleep, and
weight gain), suicide ideation and attempts, psy-
chotic symptoms, more seasonal depressive epi-
sodes, a stronger family history of psychiatric
disorders, more lifetime depressive episodes, youn-
ger age, and earlier age at onset.
In multiple logistic regression analyses, com-
pared to MDD, BD-I was characterized by more
atypical depressive features (increased appetite,
increased sleep, and weight gain), more psychotic
symptoms, higher number of lifetime depressive
episodes, and earlier age at onset; BD-II was char-
acterized by more psychotic symptoms and earlier
age at onset (Table 2). Compared to BD-II, BD-I
was characterized by more frequent depressive epi-
sodes per year [odds ratio (OR) = 3.1, 95% confi-
dence interval (CI): 1.5–6.6; p = 0.002].
Discussion
To the best of our knowledge, this is the first study
systematically to compare the sociodemographic
and clinical features between patients with MDD
and those with BD-I or BD–II who have been
misdiagnosed with MDD in China. We also have
found no previous studies that have identified
undiagnosed BD patients using the MINI and then
compared their demographic and clinical features
to those with MDD in other settings. Earlier stud-
ies have found that accurate diagnosis of BD
usually takes eight to ten years (13) and BD, par-
ticularly BD-II, is frequently misdiagnosed as
MDD, resulting in inadequate or inappropriate
treatment (2, 5). The failure to treat with mood sta-
bilizers in BD may lead to more frequent mood
episodes, precipitation of a mixed state, increased
risk of suicidal behaviors, and poorer outcome in
general (14, 15). Therefore, correctly diagnosing
BD in depressed patients has vitally important
clinical implications. Similar to the findings of pre-
vious studies (16–21), the clinical presentation of
depression in both BD-I and BD-II patients in the
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present study were different from that of MDD
patients, particularly in terms of atypical depres-
sive features and psychotic symptoms, which were
twice as frequent during depressive episodes in BD
than in MDD.
Western studies have found that patients with
BD-I or BD-II may have a ten-year earlier age at
onset than those with MDD (21–23), and the gap
between the age at onset of BD and of MDD prob-
ably has a strong genetic basis (24). In the present
study, BD-I and BD-II patients had a younger age
at onset than MDD patients (28.0 versus 28.8 ver-
sus 34.6 years, respectively). In addition, the age at
onset of BD patients was considerably older than
those in most [21.2 years (15); 22.7 years (25)], but
not all [29.0 years (21)] Western studies. The possi-
ble biological or methodological reasons for the
differences in results concerning age at onset need
to be explored in future studies.
Cardiovascular mortality in BD patients is
higher than that in MDD patients (26, 27). In the
present study, in contrast to MDD, BD-I was more
frequently characterized by atypical depressive fea-
tures (increased appetite, increased sleep, and
weight gain) that are risk factors for metabolic syn-
drome and are associated with cardiovascular dis-
eases (28).
It was reported that younger age of onset, high
recurrence of depressive episodes, atypical depres-
sive features, psychotic symptoms, and a positive
family history are classic validators of BD in Wes-
tern settings (6, 12, 24). Most of these validators are
also applicable to the Chinese patients involved in
the present multicenter study. However, it is note-
worthy that in Chinese patients BD-I and BD-II
have different clinical presentations; BD-I was char-
acterized by more frequent depressive episodes rela-
tive to BD-II after controlling for other variables.
The major merits of the present study were its
large, multicenter sample and the standardized
diagnostic assessment of BD. The results should
be interpreted with caution because of some
methodological limitations. First, as the survey
only comprised consecutively recruited inpatients
and outpatients receiving treatment for MDD in
13 major psychiatric hospitals/units, the results
cannot be applied to all clinical settings in China.
In addition, because of the cross-sectional nature
of the study, the switching process from MDD
to BD could not be observed. Prospective studies
are warranted to address the switching process.
Second, no standardized instruments were used
to measure the severity of depressive symptoms.
However, an earlier study using the Montgomery
–Asberg Depression Rating Scale (MADRS)
found that no individual depressive symptoms
discriminated between BD and MDD (15). Third,
although inpatients and outpatients were both
included in this study, their status (inpatient ver-
sus outpatient) at study entry was not recorded,
so the influence of the treatment setting on the
misdiagnosis of BD could not be explored.
Fourth, some important clinical and psychosocial
factors were not measured, such as the duration
of contact with clinical services, particularly psy-
chiatric services, and the estimated duration for
which the patient remained misdiagnosed despite
the first occurrence of a hypomanic or manic
episode.
In conclusion, although there are currently no
widely accepted diagnostic dividing lines between
BD depression and MDD in clinical practice, our
results indicate that there are subtle differences
between the forms of depressive episodes occurring
in the context of BD and MDD, the clinical use of
which might be helpful in distinguishing BD from
MDD in Chinese patients.
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